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Abstract  
Many diseases are defined by patterns of DNA methylation which result in aberrant 
gene expression. We present a rapid assay based upon Resistive Pulse Sensing, 
RPS, to characterise sequence specific DNA methylation sites in genomic DNA. We 
modify the surface of superparamagnetic beads, SPBs, with DNA (capture probe). 
The particles are added to solution where they bind to and extract sequence specific 
DNA (Target DNA). The target loaded SPBs are then incubated with antibodies 
which bind to the methylation sites, and the velocity of the SPBs through the 
nanopore reveals the number and location of the epigenetic markers within the target. 
The approach is capable of distinguishing between different methylation sites within 
a DNA promoter region. Crucially the approach is not dependant on accurate 
sequencing of assayed DNA, with genomic regions targeted through complimentary 
probes. As such the number of stages and reagents costs are low and the assay is 
complete in under 60 mins which includes the incubation and run times. The format 
also allows simultaneous quantification of number of copies of methylated DNA, and 
we illustrate this with a dose response curve.  
Keywords: nanopore, resistive pulse sensor, epigenetics, methylation, 
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One of the most challenging goals in modern bioscience remains; how can we 
understand disease through analysis of biological variation?  In the post genomic era, 
quantitative bioscience has been dominated by seeking the answer through analysis 
of genomic and transcriptomic variation. This arises not from an ad-hoc 
understanding of the pre-eminence of these components, but rather the relative ease, 
scope and reliability of the underlying measurements.  As our repertoire of 
quantitative tools expands and improves, so does our understanding of the role of 
metabolomic1, proteomic2 and epigenetic3 dysregulation in disease.  
The role of DNA methylation has been shown to be fundamental to many processes 
including aging4, exercise and cancer3.  In fact cancer specific DNA methylation 
patterns have been observed across many tumours5. Despite the potential utility of 
methylation assays their adoption in the clinic and the lab has been far from absolute 
due to inherent challenges. Methods for measuring DNA methylation often rely on 
chemical modification through bisulfite treatment6.  Treatment of cytosine with 
bisulfite leads to conversion to uracil, a reaction that is prevented in 5-methylcytosine.  
The modified base (or lack thereof) can be identified through sequencing or 
hybridisation of sequence specific primers and subsequent PCR amplification.   
Many problems arise with bisulfite conversion and subsequent assay, including DNA 
degradation, reaction by-products leading to alternative modifications, a requisite for 
large sample quantities, PCR bias, etc7. 
Recent studies have demonstrated the potential of solid state nanopores in 
identifying DNA methylation sites8–10.  By binding MBD (methyl binding domain) 
proteins to 5-methylcytosine sites, they were able to observe a 3-fold increase 
ionic blockage current relative to unmethylated DNA. The technique avoids the 
need for bisulfite conversion and its inherent problems, yet requires detailed 
sequence analysis on the nanopore platform.  
Tunable Resistive Pulse Sensing (TRPS) is a solid state nanopore technique based 
upon the Coulter principle11,12. Such technologies have been applied to the 
characterisation of biological and nanomaterials11,13–17. We have previously 
demonstrated the capacity of the technique to quantify DNA protein interactions, in 
the form of a bound protein biomarker to a DNA aptamer18–21.  In the assay DNA was 
conjugated to superparamagnetic beads, SPBs, creating a negatively charged 
surface.  Protein binding to this DNA changes the charge density around the particle 
and consequently reduces its velocity as it traverses the nanopore. The decrease is 
proportional to the concentration of protein in solution.   
Rassf1a is a tumour suppressor gene, repression of which has been associated with 
a range of cancers22. Hypermethylation of CpG islands in the promoter of Rassf1a is 
prognostic of its dysregulation, with degree of methylation inversely correlated with 
gene expression23. We assess the ability of TRPS to determine the level of 
methylation in a proportion (54 bases) of the promoter region of Rassf1a.  Anti-5-
methylcytosine antibody (an antibody that specifically binds methylation sites in 
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single stranded DNA) is bound to the promoter (target), which is anchored to a 
nanoparticle through a complementary (capture) probe.  Measuring the degree to 
which the DNA charge is shielded by the antibody will determine the level of 
methylation. Crucially the assay negates the requirement of the pore to sequence 
the DNA, with specific genomic regions targeted through hybridisaton to 
complementary probes.  
The aim is to produce a rapid, reliable assay for methylation, with applications 
ranging from the clinic to the farming industry24. We find the assay is highly sensitive 
in discriminating between methylated and unmethylated sequences. In addition 
methylation sites at different points in the sequence could be distinguished in the ion 
blockage profiles of the nanoparticles as they traversed the pore.  The assay also 
correlates particle velocity with number of methylations sites in the promoter region, 
where by the presence of single or double epigenetic markers can be identified. The 
number of methylated target DNAs in solution allows a dose response curve for the 
quantification of methylated DNA in solution over two orders of magnitude. 
Experimental 
Chemicals and Reagents 
A 54 base region from the Rasf1a promoter sequence from chromosome III of the 
human genome was selected (5’-GG[met1-C]CCGCCCTGTGGCCCCG[met2-
C]CCGGCCCGCGCTTGCTAGCGCCCAAAGCCAGCGA-3’), this is to simulate the 
product of a restriction enzyme digest. A 30 base capture probe complementary to 
the the Rassf1 promotor sequence, was purchased from Sigma Aldrich Chemicals 
with a 5’ biotin tag and 5T linker (biotin-
TTTTTTCGCTGGCTTTGGGCGCTAGCAAGC). In addition four variations of the 
Rassf1a promoter: unmethylated ControlDNA, 5’ single methylation (at site met1-C 
above EndDNA), 3’ single methylation (site met2-C MiddleDNA) and double 
methylation (sites met1-C and met2-C DoubleDNA), were also purchased in 
lyophilised powders with RP1 purification from Sigma Aldrich Chemicals (UK). Anti-
5-methylcytosine antibody at 1 mg/mL (ab73938) was purchased from Abcam, UK. 
The concentration of the antibody was verified using UV-Vis spectroscopy 
(Nanodrop 2000, ThermoFisher Scientific). Using the average MW of the antibody 
(970 000 g/Mol) the number of antibodies per unit volume could be established and 
used for ratio calculations. Water purified to a resistivity of 18.2 MΩ cm (Maxima) 
was used to make all solutions. Phosphate buffered saline (PBS, P4417 (1× PBS 
tablet (0.01 M phosphate buffer, 0.0027 M potassium chloride, 0.137 M sodium 
chloride) in 200 mL deionised water (18.2MΩcm)).) was purchased from Sigma 
Aldrich (UK) and used unmodified through the experiment. Carboxylated polystyrene 
beads, denoted as CPC200, with a mean nominal diameter of 210 nm and stock 
concentration of 1 × 1012 particles/mL, were purchased from Bangs Laboratories, 
USA and used as a concentration calibrant at 2 x 109/mL. Prior to use the beads 
were vortexed for 30 s and sonicated for 1 min to ensure monodispersity.  
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Preparation of SPB 
120 nm streptavidin coated beads (Ademtech 03211) were used and functionalized 
with the biotin labelled capture probe with the Rassf1a promoter sequence as follows: 
Equal volumes of oligonucleotides, corresponding to 100% of the beads binding 
capacity (calculated using the manufacturer’s specification) of the streptavidin 
modified beads, were vortexed for 30 s prior to heating to 95°C for 5 min in a mini 
drybath (Benchmark Scientific, USA). The reaction mixture was vortexed again for 
30 s and allowed to cool to RT for 30 min on a rotary wheel before the addition of 
beads.  The mixture was placed on a MagRack (Life Science) for 10 min until a 
cluster of beads was visible. The solution was carefully removed and replaced with 
an equal volume of PBS. The concentration of beads was kept constant throughout 
all experiments at 2 x 109/mL.   
Concentration Analysis 
Anti-5-methylcytosine antibody (a pentameric IgM) was added to the DNA hybridised 
beads. The ratio of antibodies to beads varied from 0 up to three orders of 
magnitude of antibodies per bead. After the addition of the antibody the mixtures 
were vortexed for 30 s and placed on a rotary wheel for 8 min and prior to TRPS 
analysis the mixture was vortexed for 15 s and sonicated for 5 s.   
Dose Response 
Full-Binding Capacity Experiment - The concentration of Rassf1 was maintained at 
100% relative to the binding capacity of the beads, to which varied amounts of 
complementary DNA equivalent to 0, 10, 20, 40, 60, 80, and 100% of the bead’s 
binding capacity were added. The bound DNA sequences were then hybridised to 
the beads as previously described. The concentration of anti-5-methylcytosine 
antibody was maintained at three orders of magnitude relative to the bead 
concentration.  
Half-Binding Capacity Experiment - Throughout this set of experiments the Rassf1 
concentration was kept constant – 50% of the beads binding capacity. The bead 
binding capacity is calculated to be half using the manufacturer’s specifications and 
assumed from previous studies21,25. The amount of complementary DNA varied from 
0, 10, 20, 30, and 40% of the beads binding capacity. As previously described the 
bound DNA was hybridised to the beads with the concentration of anti-5-
methylcytosine antibody maintained at three orders of magnitude relative to the bead 
concentration.  
TRPS Analysis 
 
TRPS was performed using the qNano system purchased from IZON Science (New 
Zealand). The technique uses elastomeric tunable nanopores with Izon’s own data 
capturing software Izon Control Suite (V3.1.2.53). NP200 pores were used, suitable 
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for analysing beads between 85 and 500 nm (stated by the manufacturer).  An 
appropriate stretch and voltage were applied throughout so that the blockades of 
CPC200s in PBS were at least 0.5 nA above the background noise; a measure to 
account for the variations in pore manufacturing. The operation of the qNano is 
described elsewhere12,18,26 but briefly: the lower fluid cell was filled with 75 µL of PBS, 
ensuring no air bubbles are present and the upper fluid cell contained 40 µL of the 
sample. After each measurement the sample was removed from the upper fluid cell 
and replaced with PBS. This was repeated several times, applying varying amounts 
of pressure and vacuum, until visible blockades were no longer observed. Samples 
were replicated in triplicate, unless stated with H15 estimates of the mean reported 
and used for normalisation.  
 
Calculating the particle velocities  
The method used the resistive pulse to calculate the relative velocity, and identifies 
the point of greatest resistance in the signal trace (the resistive blockade peak).  For 
each blockade, the time at which the peak occurs is defined as T1.0 (time at 100% of 
peak magnitude) and the maximum magnitude of the pulse (relative to the local 
baseline resistance) is recorded as dRmax. Here the value at T0.5 (width of the pulse 
at 50% of the peak magnitude is used)25,27. To keep the method simple and 
applicable in further applications the actual zeta potential of the particle is not 
calculated and for further simplicity in the subsequent figures we use only one 
measurement to represent the particle speed which is 1/T0.50.   
Results and Discussion 
The outline for the assay is shown in fig 1. Here a synthesised target is used, 
however it should be noted the concept can be adapted to any working assay where 
the genomic DNA is first extracted and digested prior to analysis. A biotinylated 
capture probe is added to the DNA sample (fig1A). The capture probe was designed 
to be a perfect complement to a flanking region of the Rassf1a gene where the 
methylation is known to occur. The mixture was heated to 95oC for 5 min to denature 
the target DNA. The mixture was then allowed to cool to RT for 30 min allowing the 
biotinylated probe to hybridise to its target. Streptavidin coated superparamagetic 
beads, SPBs, were then added to the solution, mixed for 5 min (fig1B) and extracted 
using a magnetic rack before being finally placed into PBS buffer. During this 
extraction the aim was to allow the SPBs to bind the biotinytated capture DNA along 
with the hybridised target DNA (fig 1D). 
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Fig 1. Schematic of the assay. A) Biotinyated Capture probe is incubated with the target DNA. B) 
Streptavidin coated SPBs capture the DNA. C) Antibody is added to the solution. D) Depending upon 
the target DNA present the SPBs have i – Capture DNA, ii – unmethylated Target DNA, iii – single 
methylated site (MidDNA) iv – single methylation (EndDNA) or v – two methylation sites (DoubleDNA). 
E – The velocity of the particles through the RPS reveals which target is present.  
The concentration of SPBs added to the solution was adjusted such that their total 
binding capacity was equal to the concentration of biotinylated DNA.  This results in 
the extracted SPBs always having a coating of DNA even in the absence of target 
DNA (Fig1Di). We have recently shown how the length and concentration of single 
and double stranded DNA on SPBs can be monitored using TRPS26. We utilise the 
same concept and signal transduction mechanism here. In summary the binding of 
DNA to the SPBs results in the zeta potential of the particles becoming more 
negative. The change in zeta potential is measured by monitoring the translocation 
velocity of the particles through the pore, and measured via the full width half 
maximum, FWHM, (fig1E). Increasing the number of DNA molecules or the length of 
the sequence around each SPB results in an increase in zeta potential, inferred by 
an increase in 1/T0.5 i.e. more negatively charged particles move through the pore 
quicker. An example of this is shown in fig 2. The relative velocity of the particles is 
then plotted as the reciprocal of T0.5 and shown for Streptavidin SPBs (blank), 
capture probe modified SPBs (ssDNA) and target probe modified SPBs (dsDNA). 
The relative order of the velocity of the three particles shows that the target DNA is 
faster than capture probe only, and the slowest particles are the blank SPBs.   
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Fig 2. Left, Plot of 1/T0.5 versus frequency for SPB modified with no DNA curve A (Blank). Capture 
probed modified DNA (ssDNA) curve B, and SPBs with target DNA curve C (dsDNA). Right, same 
data visualised as box-whisker plots. Events for DNA type and blank beads >500 
Here we do not convert the translocation velocities into zeta potential values, as it’s 
not required and adds an extra stage within the calibration. Monitoring the relative 
change in velocities of the particles is sufficient to determine the presence of the 
DNA.  
Having captured the target DNA, the next stage was to assess if the methylated 
bases within the target DNA could be identified. Two samples were prepared, the 
first was a target DNA with no methylation makers, and the second with a single 
methylation point approx. half way within the sequence (MidDNA) fig 1D ii and iii, 
respectively. The anti-methyl antibody was incubated with the SPBs and if epigenetic 
markers are present, they should bind to the DNA. We have recently demonstrated 
how the TRPS system can monitor Protein-DNA interactions and is the basis for 
many aptamer based sensors. The binding of the antibody to the DNA changes the 
charge density around the particles and results in a change in particle 
velocities18,20,21,28. A decrease in velocity (with respect to a positive bias below the 
pore) is thought to be due to several parameters. Changes to the DNA structure as it 
binds the protein may require an increased number of counter ions to stabilise any 
tertiary structure, secondly the protein’s pI is between 6-7.4, and therefore has a net 
(and slight) positive charge for the pH used in the experiment, which can counter the 
charge on the DNA backbone. In addition, the binding of the protein (even if in a net 
neutral charge state) to the DNA will disrupt the double layer structure and affect the 
electrophoretic velocity. 
To test this hypothesis and to optimise the amount of antibody required, we titrated 
differing Bead:Antibody ratios shown in fig 3a (and Fig S1). For the methylated 
sample, as the number of antibodies per bead increases from 0 up to three orders of 
magnitude (~1:1000), the particle velocity decreases as they bind to the DNA.  Whilst 
there is a selective interaction between the antibody and methylation site, there will 
be some nonspecific interactions between the antibody and DNA. Thus at the larger 
concentrations of antibody we attribute the change in velocity for the nonmethylated 
DNA to nonspecific interactions between the IgM and the DNA/ beads surface. It 
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should also be noted that whilst the binding of the antibody changes the relative 
velocity of the particle, we do not observe within the current setup a change in 
particle volume.  
We repeated this experiment using target DNA which contained a single methylation 
site at a different location further from the bead surface (EndDNA) Fig 1Div, and a 
target DNA which contained two methylation sites (DoubleDNA) Fig 1Dv. Similar 
trends were observed i.e. as the antibody number increased the particle velocity 
decreased at a rate much higher than the control. It should be noted that in no case 
did we see particle aggregation, and the particle size distribution plots are given in 
supplementary fig S2.  In the presence of nonspecific interactions taking place at 
higher antibody numbers it was concluded that a ratio of three orders of magnitude 
more antibodies to bead was a suitable ratio to proceed with further experiments.  
 
Fig 3 (a) Normalised 1/T0.5 values as a function of antibody per SPB. The ratio of SPBs:antibody was 
varied for all four types DNA used to determine methylation site. Magenta shows data for ControlDNA, 
in which no methylation is present; green represents EndDNA; red MiddleDNA; and blue the doubly 
methylated DoubleDNA (b) Translocation velocities distributions taken from 1/T0.5 of the four DNA 
types. The ratio of SPBs:Antibody is constant at three orders of magnitude more antibodies per SPBs, 
with the concentration of capture DNA and target equivalent to 100% of the SPBs binding capacity. 
Black distributions represent when no antibody is present.  Events for each data point >400. 
We hypothesised that the location at which the antibody bound to the DNA, i.e. if the 
methylation site was in the Mid, End or Double, may result in different magnitudes of 
velocity change helping identify the location of the methylation site. However as can 
be seen in fig3B the mean velocity change and distribution of velocities for hundreds 
of particles are similar in this design of the experiment. 
From the above experimental design, the presence of the epigenetic marker could 
be easily identified. To quantify the number of DNA copies in solution which 
contained these markers, we prepared a dose response curve. To demonstrate this 
we chose the MidDNA. In this experiment the number of SPBs, the concentration of 
capture DNA and antibody ratio was kept constant. The concentration of target DNA 
was varied and the results shown in fig 4a. The dose response curve shows a 
change over 2 orders of magnitude. As the number of target DNA increases the 
9 
 
velocity of the particles decrease. At lower concentrations of target DNA most of the 
SPBs surface is covered with biotinylated capture probe, and as it does not bind to 
the antibody, its negative charge dominates the particles velocity. To improve the 
sensitivity of the dose response curve at lower concentrations of target DNA, we 
lowered the number of capture probes to be circa 50% of the binding capacity of the 
beads, i.e. keeping every other parameter the same as fig 4a but the concentration 
of the capture probe was halved. The ratio of the bead concentration, binding 
capacity, capture probe capacity and numbers of antibodies are given in table 1.  
 
Bead to antibody ratio* Capture Probe 
Concentration Relative to 
the Bead’s Binding 
Capacity (%) 
Target EndDNA 
Concentration 
Relative to the Bead’s 
Binding Capacity (%) 
1:1000  100 0 
1:1000  100 10 
1:1000  100 20 
1:1000  100 40 
1:1000  100 60 
1:1000  100 80 
1:1000  100 100 
   
1:1000  50 0 
1:1000  50 10 
1:1000  50 20 
1:1000  50 30 
1:1000  50 40 
Table 1. Concentration of SPB, capture probe and antibodies in Assays. *the bead to 
antibody ratio is an approximation and is referred to as three orders of magnitude in 
the text 
 
Fig 4 Concentration of beads was kept constant at 2 x 109/mL. (a) Concentration of capture probe is 
100% relative to the binding capacity of the bead. The concentration of target EndDNA was varied 
from 0 – 100%, relative to the binding capacity of the bead. (b) Concentration of capture probe is 50%, 
relative to the binding capacity of bead. Again the concentration of target EndDNA was varied from 0 
– 40% of the beads binding capacity. Events for each data point >500 
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As can be seen in fig 4B halving the capture probe concentration resulted in a sharp 
decrease in velocity of the SPBs and the concentration of target DNA was increased 
from 0 nM to 119 nM. The dynamic range of this assay is lower than that in fig 4A as 
the beads can only capture half the concentration of target DNA, and at 
concentrations above 47.6 nM, there was no further decrease in velocity. Owing to 
the rapid change in velocity for the lower concentrations of capture probe we again 
measured the 1/T0.5 for the Mid, End and DoubleDNA targets to see if their relative 
velocities differentiated. Table 2 shows the change in velocity for the same 
concentrations of SPB, antibody and target DNA for the different variations of 
epigenetic target DNA.  
 
DNA Type Mean Velocity, 1/T0.5 
ms 
Standard Deviation Velocity Decrease, % 
Double 2.76 0.36 50.73 
Middle 3.39 0.31 39.48 
End 2.94 0.41 47.56 
Blank 5.60 0.22 - 
Table 2. Relative velocity for the SPB modify with capture DNA (Blank), Mid, End and Double DNA. 
The concentration of DNA was 50% relative to the binding capacity of the beads, 30% target DNA, 
beads 2 x 109/mL and antibody three orders of magnitude more antibody per bead. Events for each 
DNA type, and blank >600 (blank 2303; MiddleDNA 932; EndDNA 979; and DoubleDNA 686). 
Table 2 shows that the largest change in velocity was observed for the double 
methyl target, followed by the end and middle. At the lower concentrations of capture 
probe the relative velocity of the beads allows differentiation of the location of the 
epigenetic marker. At these lower concentrations of capture probe the average 
distance between neighbouring DNA on the SPB’s surface increases, this may allow 
the antibody-DNA to adopt a different structure/ bind easier than in the fully packed 
SPB experiment. Although it should be noted that the middle methylation target still 
shows a change in velocity and thus binding to the antibody must still take place.  
Conclusion 
We demonstrate the characterisation of methylated DNA sequences through TRPS. 
The process allows for the rapid quantification of epigenetic markers with insight into 
the location of the marker within the target. The capacity of the technique to quickly 
and reliably quantify nucleic acid-protein interactions presents a platform for the 
potential analysis of: polysome gradients (translation rate), RNA methylation (anti-5-
methylcytosine also binds methylated RNA), protein phosphorylation and histone 
acetylation. This is in addition to previous studies that have demonstrated the ability 
of TRPS to quantify SNPS, microvesicles, protein biomarkers etc. TRPS is a 
burgeoning technology that lends itself to multiomic analysis, we highlight its 
application in the characterisation of methylation sites within DNA. Further 
optimisation of the approach may yield a multipurpose tool for the clinic capable of 
analysing biological variation beyond the scope of current technologies. 
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Associated Content  
Supporting Information Available: The following files are available free of charge. 
Blockade magnitude distributions for the assays and concentration analysis graphs. 
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